-
1
-
-
0037819284
-
Pharmacogenomics of human UDP-glucuronosyl-transferase enzymes
-
Guillemette, C. Pharmacogenomics of human UDP-glucuronosyl-transferase enzymes. Pharmacogenom. J., 2003, 3(3), 136-158.
-
(2003)
Pharmacogenom. J.
, vol.3
, Issue.3
, pp. 136-158
-
-
Guillemette, C.1
-
2
-
-
10744227696
-
Glucuronidation and the UDP-glucuronosyltransferases in health and disease
-
Wells, P. G.; Mackenzie, P. I.; Chowdhury, J. R.; Guillemette, C.; Gregory, P. A.; Ishii, Y.; Hansen, A. J.; Kessler, F. K.; Kim, P. M.; Chowdhury, N. R.; Ritter, J. K. Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab. Dispos., 2004, 32(3), 281-290.
-
(2004)
Drug Metab. Dispos.
, vol.32
, Issue.3
, pp. 281-290
-
-
Wells, P.G.1
Mackenzie, P.I.2
Chowdhury, J.R.3
Guillemette, C.4
Gregory, P.A.5
Ishii, Y.6
Hansen, A.J.7
Kessler, F.K.8
Kim, P.M.9
Chowdhury, N.R.10
Ritter, J.K.11
-
3
-
-
0032707765
-
Structural and functional studies of UDP-glucuronosyltransferases
-
Radominska-Pandya, A.; Czernik, P. J.; Little, J. M.; Battaglia, E.; Mackenzie, P. I. Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab. Rev., 1999, 31(4), 817-899.
-
(1999)
Drug Metab. Rev.
, vol.31
, Issue.4
, pp. 817-899
-
-
Radominska-Pandya, A.1
Czernik, P.J.2
Little, J.M.3
Battaglia, E.4
Mackenzie, P.I.5
-
4
-
-
0034128936
-
Human UDP-glucuronosyl-transferases: Metabolism, expression, and disease
-
Tukey, R. H.; Strassburg, C. P. Human UDP-glucuronosyl-transferases: metabolism, expression, and disease. Annu. Rev.Pharmacol. Toxicol., 2000, 40, 581-616.
-
(2000)
Annu. Rev.Pharmacol. Toxicol.
, vol.40
, pp. 581-616
-
-
Tukey, R.H.1
Strassburg, C.P.2
-
5
-
-
0038824200
-
Regulation of UDP glucuronosyltransferase genes
-
Mackenzie, P. I.; Gregory, P. A.; Gardner-Stephen, D. A.; Lewin-sky, R. H.; Jorgensen, B. R.; Nishiyama, T.; Xie, W.; Radominska-Pandya, A. Regulation of UDP glucuronosyltransferase genes.Curr. Drug Metab., 2003, 4(3), 249-257.
-
(2003)
Curr. Drug Metab
, vol.4
, Issue.3
, pp. 249-257
-
-
Mackenzie, P.I.1
Gregory, P.A.2
Gardner-Stephen, D.A.3
Lewin-Sky, R.H.4
Jorgensen, B.R.5
Nishiyama, T.6
Xie, W.7
Radominska-Pandya, A.8
-
6
-
-
0345168229
-
Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans
-
Belanger, A.; Pelletier, G.; Labrie, F.; Barbier, O.; Chouinard, S. Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol. Metab., 2003, 14(10), 473-479.
-
(2003)
Trends Endocrinol. Metab
, vol.14
, Issue.10
, pp. 473-479
-
-
Belanger, A.1
Pelletier, G.2
Labrie, F.3
Barbier, O.4
Chouinard, S.5
-
7
-
-
0033661491
-
Tissue distribution and interindividual variation in human UDP-glucuronosyl-transferase activity: Relationship between UGT1A1 promoter geno-type and variability in a liver bank
-
Fisher, M. B.; Vandenbranden, M.; Findlay, K.; Burchell, B.; Thummel, K. E.; Hall, S. D.; Wrighton, S. A. Tissue distribution and interindividual variation in human UDP-glucuronosyl-transferase activity: relationship between UGT1A1 promoter geno-type and variability in a liver bank. Pharmacogenetics, 2000, 10(8), 727-739.
-
(2000)
Pharmacogenetics
, vol.10
, Issue.8
, pp. 727-739
-
-
Fisher, M.B.1
Vandenbranden, M.2
Findlay, K.3
Burchell, B.4
Thummel, K.E.5
Hall, S.D.6
Wrighton, S.A.7
-
8
-
-
0035209568
-
Therole of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism
-
Fisher, M. B.; Paine, M. F.; Strelevitz, T. J.; Wrighton, S. A. Therole of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab. Rev., 2001, 33(3-4), 273-297.
-
(2001)
Drug Metab. Rev.
, vol.33
, Issue.3-4
, pp. 273-297
-
-
Fisher, M.B.1
Paine, M.F.2
Strelevitz, T.J.3
Wrighton, S.A.4
-
9
-
-
0032568310
-
Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group
-
Schwartz, S.; Raskin, P.; Fonseca, V.; Graveline, J. F. Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group. N. Engl. J. Med., 1998, 338(13), 861-866.
-
(1998)
N. Engl. J. Med.
, vol.338
, Issue.13
, pp. 861-866
-
-
Schwartz, S.1
Raskin, P.2
Fonseca, V.3
Graveline, J.F.4
-
10
-
-
0032568257
-
Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus
-
Inzucchi, S. E.; Maggs, D. G.; Spollett, G. R.; Page, S. L.; Rife, F. S.; Walton, V.; Shulman, G. I. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N. Engl. J. Med., 1998, 338(13), 867-872.
-
(1998)
N. Engl. J. Med.
, vol.338
, Issue.13
, pp. 867-872
-
-
Inzucchi, S.E.1
Maggs, D.G.2
Spollett, G.R.3
Page, S.L.4
Rife, F.S.5
Walton, V.6
Shulman, G.I.7
-
11
-
-
0035879932
-
Troglitazone quinone formation catalyzed by human and rat CYP3A: An atypical CYP oxidation reaction
-
He, K.; Woolf, T. F.; Kindt, E. K.; Fielder, A. E.; Talaat, R. E. Troglitazone quinone formation catalyzed by human and rat CYP3A: an atypical CYP oxidation reaction. Biochem. Pharmacol., 2001, 62(2), 191-198.
-
(2001)
Biochem. Pharmacol.
, vol.62
, Issue.2
, pp. 191-198
-
-
He, K.1
Woolf, T.F.2
Kindt, E.K.3
Fielder, A.E.4
Talaat, R.E.5
-
12
-
-
23344450788
-
Induction of phase I, II and III drug metabolism/transport by xenobiotics
-
Xu, C.; Li, C. Y.; Kong, A. N. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res., 2005, 28(3), 249-268.
-
(2005)
Arch. Pharm. Res.
, vol.28
, Issue.3
, pp. 249-268
-
-
Xu, C.1
Li, C.Y.2
Kong, A.N.3
-
13
-
-
23144464155
-
Xenobiotic nuclear receptor-mediated regulation of UDP-glucuronosyl-transferases
-
Zhou, J.; Zhang, J.; Xie, W. Xenobiotic nuclear receptor-mediated regulation of UDP-glucuronosyl-transferases. Curr. Drug Metab., 2005, 6(4), 289-298.
-
(2005)
Curr. Drug Metab.
, vol.6
, Issue.4
, pp. 289-298
-
-
Zhou, J.1
Zhang, J.2
Xie, W.3
-
14
-
-
34247349605
-
Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: Implications for interindividual variability in response to drugs
-
Urquhart, B. L.; Tirona, R. G.; Kim, R. B. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J. Clin. Pharmacol., 2007, 47(5), 566-578.
-
(2007)
J. Clin. Pharmacol.
, vol.47
, Issue.5
, pp. 566-578
-
-
Urquhart, B.L.1
Tirona, R.G.2
Kim, R.B.3
-
15
-
-
1042287037
-
The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics
-
Sugatani, J.; Yamakawa, K.; Tonda, E.; Nishitani, S.; Yoshinari, K.; Degawa, M.; Abe, I.; Noguchi, H.; Miwa, M. The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics. Biochem. Pharmacol., 2004, 67(5), 989-1000.
-
(2004)
Biochem. Pharmacol.
, vol.67
, Issue.5
, pp. 989-1000
-
-
Sugatani, J.1
Yamakawa, K.2
Tonda, E.3
Nishitani, S.4
Yoshinari, K.5
Degawa, M.6
Abe, I.7
Noguchi, H.8
Miwa, M.9
-
16
-
-
14944341677
-
Transcriptional regulation of human UGT1A1 gene expression: Activated glucocorticoid receptor enhances constitutive androstane receptor/pregnane X receptor-mediated UDP-glucuronosyltransferase 1A1 regulation with glucocorticoid receptor-interacting protein 1
-
Sugatani, J.; Nishitani, S.; Yamakawa, K.; Yoshinari, K.; Sueyoshi, T.; Negishi, M.; Miwa, M. Transcriptional regulation of human UGT1A1 gene expression: activated glucocorticoid receptor enhances constitutive androstane receptor/pregnane X receptor-mediated UDP-glucuronosyltransferase 1A1 regulation with glucocorticoid receptor-interacting protein 1. Mol. Pharmacol., 2005, 67(3), 845-855.
-
(2005)
Mol. Pharmacol.
, vol.67
, Issue.3
, pp. 845-855
-
-
Sugatani, J.1
Nishitani, S.2
Yamakawa, K.3
Yoshinari, K.4
Sueyoshi, T.5
Negishi, M.6
Miwa, M.7
-
17
-
-
17644364027
-
Modulation of UDP-glucuronosyltransferase 1A1 in primary human hepatocytes by prototypical inducers
-
Smith, C. M.; Faucette, S. R.; Wang, H.; LeCluyse, E. L. Modulation of UDP-glucuronosyltransferase 1A1 in primary human hepatocytes by prototypical inducers. J. Biochem. Mol. Toxicol., 2005, 19(2), 96-108.
-
(2005)
J. Biochem. Mol. Toxicol.
, vol.19
, Issue.2
, pp. 96-108
-
-
Smith, C.M.1
Faucette, S.R.2
Wang, H.3
Lecluyse, E.L.4
-
18
-
-
33749035441
-
Reporter gene Cellular Model for Evaluating Induction of CYP3A4 by New Chemical Entities
-
Enoru-Eta, J. Y.; L.G.; Kao, J.; Scatina, J. A.; Reporter gene Cellular Model for Evaluating Induction of CYP3A4 by New Chemical Entities. Drug Develop. Res., 2006, 67(5), 470-475.
-
(2006)
Drug Develop. Res.
, vol.67
, Issue.5
, pp. 470-475
-
-
Enoru-Eta, J.Y.1
-
19
-
-
0032791711
-
Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: Evidence for both genetic and environmental influences
-
Ritter, J. K.; Kessler, F. K.; Thompson, M. T.; Grove, A. D.; Auyeung, D. J.; Fisher, R. A. Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: evidence for both genetic and environmental influences. Hepatology, 1999, 30(2), 476-484.
-
(1999)
Hepatology
, vol.30
, Issue.2
, pp. 476-484
-
-
Ritter, J.K.1
Kessler, F.K.2
Thompson, M.T.3
Grove, A.D.4
Auyeung, D.J.5
Fisher, R.A.6
-
20
-
-
0030221217
-
The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1
-
King, C. D.; Green, M. D.; Rios, G. R.; Coffman, B. L.; Owens, I. S.; Bishop, W. P.; Tephly, T. R. The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1. Arch. Biochem. Biophys., 1996, 332(1), 92-100.
-
(1996)
Arch. Biochem. Biophys.
, vol.332
, Issue.1
, pp. 92-100
-
-
King, C.D.1
Green, M.D.2
Rios, G.R.3
Coffman, B.L.4
Owens, I.S.5
Bishop, W.P.6
Tephly, T.R.7
-
21
-
-
6944221357
-
Drug-drug in-teractions for UDP-glucuronosyltransferase substrates: A pharma-cokinetic explanation for typically observed low exposure (AUCi/AUC) ratios
-
Williams, J. A.; Hyland, R.; Jones, B. C.; Smith, D. A.; Hurst, S.; Goosen, T. C.; Peterkin, V.; Koup, J. R.; Ball, S. E. Drug-drug in-teractions for UDP-glucuronosyltransferase substrates: a pharma-cokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metab. Dispos., 2004, 32(11), 1201-1208.
-
(2004)
Drug Metab. Dispos
, vol.32
, Issue.11
, pp. 1201-1208
-
-
Williams, J.A.1
Hyland, R.2
Jones, B.C.3
Smith, D.A.4
Hurst, S.5
Goosen, T.C.6
Peterkin, V.7
Koup, J.R.8
Ball, S.E.9
-
22
-
-
1642579667
-
An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes
-
Soars, M. G.; Petullo, D. M.; Eckstein, J. A.; Kasper, S. C.; Wrighton, S. A. An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes. Drug Metab. Dispos., 2004, 32(1), 140-148.
-
(2004)
Drug Metab. Dispos.
, vol.32
, Issue.1
, pp. 140-148
-
-
Soars, M.G.1
Petullo, D.M.2
Eckstein, J.A.3
Kasper, S.C.4
Wrighton, S.A.5
-
23
-
-
27744435377
-
Differential UGT1A1 induction by chrysin in primary human hepatocytes and HepG2 Cells
-
Smith, C. M.; Graham, R. A.; Krol, W. L.; Silver, I. S.; Negishi, M.; Wang, H.; Lecluyse, E. L. Differential UGT1A1 induction by chrysin in primary human hepatocytes and HepG2 Cells. J. Pharmacol. Exp. Ther., 2005, 315(3), 1256-1264.
-
(2005)
J. Pharmacol. Exp. Ther.
, vol.315
, Issue.3
, pp. 1256-1264
-
-
Smith, C.M.1
Graham, R.A.2
Krol, W.L.3
Silver, I.S.4
Negishi, M.5
Wang, H.6
Lecluyse, E.L.7
-
24
-
-
0035029401
-
The phenobarbital response enhancer module in the human bilirubin UDP- glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR
-
Sugatani, J.; Kojima, H.; Ueda, A.; Kakizaki, S.; Yoshinari, K.; Gong, Q. H.; Owens, I. S.; Negishi, M.; Sueyoshi, T. The phenobarbital response enhancer module in the human bilirubin UDP- glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology, 2001, 33(5), 1232-1238.
-
(2001)
Hepatology
, vol.33
, Issue.5
, pp. 1232-1238
-
-
Sugatani, J.1
Kojima, H.2
Ueda, A.3
Kakizaki, S.4
Yoshinari, K.5
Gong, Q.H.6
Owens, I.S.7
Negishi, M.8
Sueyoshi, T.9
-
25
-
-
0038236664
-
Involvement of the xenobiotic response element (XRE) in Ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1
-
Yueh, M. F.; Huang, Y. H.; Hiller, A.; Chen, S.; Nguyen, N.; Tukey, R. H. Involvement of the xenobiotic response element (XRE) in Ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1. J. Biol. Chem., 2003, 278(17), 15001-15006.
-
(2003)
J. Biol. Chem.
, vol.278
, Issue.17
, pp. 15001-15006
-
-
Yueh, M.F.1
Huang, Y.H.2
Hiller, A.3
Chen, S.4
Nguyen, N.5
Tukey, R.H.6
-
26
-
-
34247631742
-
The evolving role of drug metabolism in drug discovery and development
-
Yengi, L. G.; Leung, L.; Kao, J. The evolving role of drug metabolism in drug discovery and development. Pharm. Res., 2007, 24(5), 842-858.
-
(2007)
Pharm. Res.
, vol.24
, Issue.5
, pp. 842-858
-
-
Yengi, L.G.1
Leung, L.2
Kao, J.3
-
27
-
-
33846410787
-
Nuclear receptor-mediated transcriptional regulation in Phase I, II, and III xenobiotic metabolizing systems
-
Nakata, K.; Tanaka, Y.; Nakano, T.; Adachi, T.; Tanaka, H.; Ka-minuma, T.; Ishikawa, T. Nuclear receptor-mediated transcriptional regulation in Phase I, II, and III xenobiotic metabolizing systems. Drug Metab. Pharmacokinet., 2006, 21(6), 437-457.
-
(2006)
Drug Metab. Pharmacokinet.
, vol.21
, Issue.6
, pp. 437-457
-
-
Nakata, K.1
Tanaka, Y.2
Nakano, T.3
Adachi, T.4
Tanaka, H.5
Ka-Minuma, T.6
Ishikawa, T.7
-
28
-
-
18444399926
-
Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia
-
Sugatani, J.; Yamakawa, K.; Yoshinari, K.; Machida, T.; Takagi, H.; Mori, M.; Kakizaki, S.; Sueyoshi, T.; Negishi, M.; Miwa, M. Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochem. Biophys. Res. Commun., 2002, 292(2), 492-497.
-
(2002)
Biochem. Biophys. Res. Commun.
, vol.292
, Issue.2
, pp. 492-497
-
-
Sugatani, J.1
Yamakawa, K.2
Yoshinari, K.3
Machida, T.4
Takagi, H.5
Mori, M.6
Kakizaki, S.7
Sueyoshi, T.8
Negishi, M.9
Miwa, M.10
-
29
-
-
0028867826
-
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome
-
Bosma, P. J.; Chowdhury, J. R.; Bakker, C.; Gantla, S.; de Boer, A.; Oostra, B. A.; Lindhout, D.; Tytgat, G. N.; Jansen, P. L.; Oude Elferink, R. P.; Chowdhury N.R. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N. Engl. J. Med., 1995, 333(18), 1171-1175.
-
(1995)
N. Engl. J. Med.
, vol.333
, Issue.18
, pp. 1171-1175
-
-
Bosma, P.J.1
Chowdhury, J.R.2
Bakker, C.3
Gantla, S.4
de Boer, A.5
Oostra, B.A.6
Lindhout, D.7
Tytgat, G.N.8
Jansen, P.L.9
Oude Elferink, R.P.10
Chowdhury, N.R.11
-
30
-
-
0033510908
-
Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn
-
Monaghan, G.; McLellan, A.; McGeehan, A.; Li Volti, S.; Mollica, F.; Salemi, I.; Din, Z.; Cassidy, A.; Hume, R.; Burchell, B. Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn. J. Pediatr., 1999, 134(4), 441-446.
-
(1999)
J. Pediatr.
, vol.134
, Issue.4
, pp. 441-446
-
-
Monaghan, G.1
McLellan, A.2
McGeehan, A.3
Li Volti, S.4
Mollica, F.5
Salemi, I.6
Din, Z.7
Cassidy, A.8
Hume, R.9
Burchell, B.10
-
31
-
-
0030030762
-
Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome
-
Monaghan, G.; Ryan, M.; Seddon, R.; Hume, R.; Burchell, B. Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet, 1996, 347(9001), 578-581.
-
(1996)
Lancet
, vol.347
, Issue.9001
, pp. 578-581
-
-
Monaghan, G.1
Ryan, M.2
Seddon, R.3
Hume, R.4
Burchell, B.5
-
32
-
-
28844460430
-
Successful treatment of severe unconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicin
-
Ellis, E.; Wagner, M.; Lammert, F.; Nemeth, A.; Gumhold, J.; Strassburg, C. P.; Kylander, C.; Katsika, D.; Trauner, M.; Einarsson, C.; Marschall, H. U. Successful treatment of severe unconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicin. J. Hepatol., 2006, 44(1), 243-245.
-
(2006)
J. Hepatol.
, vol.44
, Issue.1
, pp. 243-245
-
-
Ellis, E.1
Wagner, M.2
Lammert, F.3
Nemeth, A.4
Gumhold, J.5
Strassburg, C.P.6
Kylander, C.7
Katsika, D.8
Trauner, M.9
Einarsson, C.10
Marschall, H.U.11
-
33
-
-
0025218656
-
Rifampin relieves pruritus in children with cholestatic liver disease
-
Cynamon, H. A.; Andres, J. M.; Iafrate, R. P. Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology, 1990, 98(4), 1013-1016.
-
(1990)
Gastroenterology
, vol.98
, Issue.4
, pp. 1013-1016
-
-
Cynamon, H.A.1
Andres, J.M.2
Iafrate, R.P.3
-
34
-
-
0032172828
-
Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gammaglutamyl transpeptidase
-
Cancado, E. L.; Leitao, R. M.; Carrilho, F. J.; Laudanna, A. A. Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gammaglutamyl transpeptidase. Am. J. Gastroenterol., 1998, 93(9), 1510-1517.
-
(1998)
Am. J. Gastroenterol.
, vol.93
, Issue.9
, pp. 1510-1517
-
-
Cancado, E.L.1
Leitao, R.M.2
Carrilho, F.J.3
Laudanna, A.A.4
-
35
-
-
0021878377
-
Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis
-
Hoensch, H. P.; Balzer, K.; Dylewizc, P.; Kirch, W.; Goebell, H.; Ohnhaus, E. E. Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis. Eur. J. Clin. Pharmacol., 1985, 28(4), 475-477.
-
(1985)
Eur. J. Clin. Pharmacol.
, vol.28
, Issue.4
, pp. 475-477
-
-
Hoensch, H.P.1
Balzer, K.2
Dylewizc, P.3
Kirch, W.4
Goebell, H.5
Ohnhaus, E.E.6
-
36
-
-
0034964158
-
Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation
-
LeCluyse, E. L. Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. Eur. J. Pharm. Sci., 2001, 13(4), 343-368.
-
(2001)
Eur. J. Pharm. Sci.
, vol.13
, Issue.4
, pp. 343-368
-
-
Lecluyse, E.L.1
-
37
-
-
0035154160
-
Application of rat hepatocyte culture to predict in vivo metabolic auto-induction: Studies with DFP, a cyclooxygenase-2 inhibitor
-
Nicoll-Griffith, D. A.; Silva, J. M.; Chauret, N.; Day, S.; Leblanc, Y.; Roy, P.; Yergey, J. A.; Dixit, R.; Patrick, D. Application of rat hepatocyte culture to predict in vivo metabolic auto-induction: studies with DFP, a cyclooxygenase-2 inhibitor. Drug Metab. Dispos., 2001, 29(2), 159-165.
-
(2001)
Drug Metab. Dispos.
, vol.29
, Issue.2
, pp. 159-165
-
-
Nicoll-Griffith, D.A.1
Silva, J.M.2
Chauret, N.3
Day, S.4
Leblanc, Y.5
Roy, P.6
Yergey, J.A.7
Dixit, R.8
Patrick, D.9
-
38
-
-
0032968777
-
Cryopreserved human hepatocytes: Characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential
-
Li, A. P.; Lu, C.; Brent, J. A.; Pham, C.; Fackett, A.; Ruegg, C. E.; Silber, P. M. Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. Chem. Biol. Interact., 1999, 121(1), 17-35.
-
(1999)
Chem. Biol. Interact.
, vol.121
, Issue.1
, pp. 17-35
-
-
Li, A.P.1
Lu, C.2
Brent, J.A.3
Pham, C.4
Fackett, A.5
Ruegg, C.E.6
Silber, P.M.7
|